The present invention relates to a pharmaceutical composition containing a mixture
of stable folding variants of recombinant bone morphogenic proteins (rBMPs) and
its use in therapy, especially in the treatment of orthopaedic and dental patients.
Specifically, the present invention relates to a pharmaceutical composition containing
a mixture of stable folding variants of at least two rBMPs or their monomers or
mutants in a suitable carrier system.